Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts
- PMID: 3053306
- DOI: 10.1111/j.1432-0436.1988.tb00588.x
Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts
Abstract
Using subcloning and manipulations of culture conditions we have isolated from the mouse myogenic cell line C2 a variant cell line that we named inducible. Unlike the progenitor cells that are referred to as permissive, inducible myoblasts differentiate poorly in Dulbecco modified Eagle medium plus fetal calf serum (FCS) and require the presence of insulin at a high concentration (1.6 10(-6) M) or insulin-like growth factor I (IGFI) at a lower concentration (2.5 10(-8) M) to differentiate. Permissive and inducible myoblasts fail to differentiate when grown in MCDB202 medium plus 20% FCS, even after a prolonged arrest in G1 phase. This shows that an arrest in G1 is in itself insufficient to trigger terminal differentiation. Both cell types also exhibit distinct patterns of accumulation of muscle mRNAs corresponding to sarcomeric actins and myosin light chain MLC1A. The possibility that these two cell lines might represent two different stages of the progression of myoblasts toward terminal differentiation is discussed.
Similar articles
-
Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.J Cell Physiol. 1994 Jun;159(3):387-98. doi: 10.1002/jcp.1041590302. J Cell Physiol. 1994. PMID: 8188756
-
Expression of MyoD1 coincides with terminal differentiation in determined but inducible muscle cells.EMBO J. 1989 Aug;8(8):2203-7. doi: 10.1002/j.1460-2075.1989.tb08343.x. EMBO J. 1989. PMID: 2551676 Free PMC article.
-
Preferential binding of insulin-like growth factor-II (IGF-II) to a putative alpha 2 beta 2 IGF-II receptor type in C2 myoblasts.Eur J Biochem. 1992 Sep 1;208(2):273-9. doi: 10.1111/j.1432-1033.1992.tb17183.x. Eur J Biochem. 1992. PMID: 1325901
-
The atypical alpha2beta2 IGF receptor expressed in inducible c2.7 myoblasts is derived from post-translational modifications of the mouse IGF-I receptor.Growth Horm IGF Res. 2008 Oct;18(5):412-423. doi: 10.1016/j.ghir.2008.03.001. Epub 2008 Apr 28. Growth Horm IGF Res. 2008. PMID: 18440847
-
Growth hormone and the insulin-like growth factor system in myogenesis.Endocr Rev. 1996 Oct;17(5):481-517. doi: 10.1210/edrv-17-5-481. Endocr Rev. 1996. PMID: 8897022 Review.
Cited by
-
The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.J Cell Biol. 1998 Sep 21;142(6):1447-59. doi: 10.1083/jcb.142.6.1447. J Cell Biol. 1998. PMID: 9744876 Free PMC article.
-
Cyclin D3 critically regulates the balance between self-renewal and differentiation in skeletal muscle stem cells.Stem Cells. 2013 Nov;31(11):2478-91. doi: 10.1002/stem.1487. Stem Cells. 2013. PMID: 23897741 Free PMC article.
-
Desminopathies: pathology and mechanisms.Acta Neuropathol. 2013 Jan;125(1):47-75. doi: 10.1007/s00401-012-1057-6. Epub 2012 Nov 11. Acta Neuropathol. 2013. PMID: 23143191 Free PMC article. Review.
-
Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells.Nucleic Acids Res. 2008 Feb;36(3):915-28. doi: 10.1093/nar/gkm1114. Epub 2007 Dec 17. Nucleic Acids Res. 2008. PMID: 18086704 Free PMC article.
-
MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration.Mol Biol Cell. 2003 May;14(5):2151-62. doi: 10.1091/mbc.e02-07-0451. Epub 2003 Jan 26. Mol Biol Cell. 2003. PMID: 12802082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous